Catch up what you missed in longevity news, anti-aging research, and the fast-growing world of biohacking.
•
Jul 26, 2026
BioAge just dosed its first patient in a Phase 2 trial testing whether a daily pill can lower cardiovascular risk by targeting inflammation. Plus: Bryan Johnson's autoimmune diagnosis takes a strange turn, and a $100M bet on the future of longevity in the UAE.
7 min read
Jul 20, 2026
First clinical evidence that semaglutide may slow biological aging. Plus: FDA approves lecanemab for home self-injection, and the Mediterranean diet just got a new molecular explanation.
6 min read
Jul 13, 2026
Scientists analyzed the blood of centenarians from the New England Centenarian Study and found a consistent set of metabolic patterns. Plus: the year's biggest Alzheimer's data event opens today in London.
Jul 8, 2026
Scientists just discovered karyoptosis - a previously unknown way neurons die in Alzheimer's and FTD. Plus: Big Pharma drops $140M on thymus rejuvenation, and Superpower tests 100+ biomarkers for $199.
Jul 1, 2026
Valter Longo studied 200,000 people and mapped the diet that extends healthspan. One amino acid makes or breaks it. Plus: the first ALS drug to hit its target in a controlled trial.
Jun 25, 2026
A study of 270,000 people links a popular focus supplement to shorter lifespans in men. Plus: laughing is longevity, the 2026 cold plunge verdict, a big longevity summit, and Oura drops the Ring 5.
Jun 20, 2026
Gone are the days of going into that claustrophobic, noisy MRI tunnel.
Jun 13, 2026
Scientists pinpoint the exact molecular trigger behind Alzheimer's inflammation.
Jun 6, 2026
How a forgotten gland in your chest quietly predicts how long you live.
5 min read
